🌍·Jan 1, 1970Regulatory
EMA recommends revoking marketing authorisation for Tavneos | European Medicines Agency (EMA)
Publisher
E
EMA Human Medicines
EU
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- EMA Human Medicines
- Region
- EU
- Scope
- Regulatory
- Published
- January 1, 1970
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on ema.europa.eu
Leave the platform to read the original full article on the publisher site.
Source: EMA Human Medicines
Scope: Regulatory
Related coverage
More related coverage
INFARMA Poland/4h ago
Stanowisko do projektu ustawy o zmianie ustawy o refundacji leków, środków spożywczych specjalnego przeznaczenia żywieniowego oraz wyrobów medycznych oraz niektórych innych ustaw
UK Health Security Agency/5h ago
UKHSA extends red heat-health alerts across England
The red heat-health alerts in place for the West Midlands, East Midlands, South East, South West, Lo...
MHRA UK/5h ago
Register medical devices to place on the market
Health Canada Recalls and Safety Alerts/8h ago
Remifentanil hydrochloride for injection; Out of specification (Assay & Impurity)
The assay and impurity is out of specification in the affected lots.